In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones
It contains three patented, plant-based ingredients, each with its own small clinical study behind it: Eriomin (lemon bioflavonoids): shown to slightly increase natural GLP-1 levels in people with elevated blood sugar [1] Supresa (saffron extract): linked to reduced snacking in mildly overweight women, although some studies found no significant effects on food cravings [2][3] Morosil (red orange extract): found to support mild fat loss over 12 weeks [4] All three ingredients are studied independently , not as a combined formula
Maximum GLP-1 weight loss of up to 22.5% achieved with consistent Mounjaro tracking over 12+ months
First, it helps you identify patterns
But then when you see the benefit of it, then he said, okay, you know what
Call our office at 832.446.3206 for a free consultation and see if you are a candidate for our Semaglutide with B12 Weight Loss Program